| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director | Common Stock | 24,937 | $1,501,706 | $60.22 | 01 May 2025 | Direct |
| HALOZYME THERAPEUTICS, INC. | Director | Option to Purchase Common Stock | 5,750 | 01 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | 01 May 2025 | 2 | $0 | 4 | Director | 02 May 2025, 16:09 |
| HALO | HALOZYME THERAPEUTICS, INC. | 25 Apr 2024 | 2 | $0 | 4 | Director | 29 Apr 2024, 18:08 |
| HALO | HALOZYME THERAPEUTICS, INC. | 05 May 2023 | 2 | $0 | 4 | Director | 09 May 2023, 18:24 |
| HALO | HALOZYME THERAPEUTICS, INC. | 05 May 2022 | 1 | $0 | 4 | Director | 06 May 2022, 20:07 |
| HALO | HALOZYME THERAPEUTICS, INC. | 24 Mar 2022 | 0 | $0 | 3 | Director | 24 Mar 2022, 16:54 |